The results of this study revealed a reduction in NAA levels in the hippocampal region of 4-month-old APP/PS1 transgenic AD model mice compared to their age-matched wild type controls, with no significant changes in other indicators. This evidence concerns the gene PSEN1 and Alzheimer disease.